Company Search:
Advanced Search
Sponsored Links
Curasan AG Company Snapshot
Curasan AG operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Curasan AG with three other pharmaceutical manufacturers in Europe: CO.DON AG (2018 sales of 5.65 million Euro [US$6.28 million] of which 100% was Product sales), Transgene of France (7.08 million Euro [US$7.86 million] of which 81% was Research & Development Tax Credit), and Medincell SA which is also based in France (6.44 million Euro [US$7.15 million] ).

Sales Analysis. Curasan AG reported sales of 5.84 million Euro (US$6.48 million) for the year ending December of 2018. This represents a decrease of 14.0% versus 2017, when the company's sales were 6.80 million Euro. The sales level in 2018 was fairly close to the level five years ago: in 2013, Curasan AG had sales of 5.83 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Curasan AG
  Stock Performance Chart for Curasan AG
  Stock Data: Recent Stock Performance:
  Current Price (1/17/2020): .99
(Figures in Euro)
1 Week -1.0%   13 Weeks 3.7%  
4 Weeks -7.0%   52 Weeks -39.0%  
Curasan AG Key Data:
  Ticker: CURK Country: Germany
  Exchanges: DUS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 5,842,000
(Year Ending Jan 2019).
Employees: 38
  Currency: Euro Market Cap: 8,975,214
  Fiscal Yr Ends: December Shares Outstanding: 9,065,873
  Share Type: Common Closely Held Shares: 2,204,786
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.